{"disease":{"id":"wegener-s-granulomatosis","name":"wegener s granulomatosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01988506","title":"Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02108860","title":"Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"University of South Florida","has_results":false},{"nct_id":"NCT02115997","title":"A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}